AMC Theatres
AMC
$2.98
+2.41%
AMC Entertainment Holdings, Inc. operates the world's largest theatrical exhibition circuit, owning, operating, or holding interests in theatres across the United States and Europe, with revenue derived primarily from admissions, food and beverage concessions, advertising, and premium-format offerings such as recliner seating, MacGuffins bars, and AMC Dine-In Theatres. As the dominant pure-play cinema operator in a secularly challenged industry, AMC's identity is that of a high-fixed-cost, scale-driven exhibitor whose fortunes are levered to box-office volume and whose equity has become a heavily retail-traded, sentiment-sensitive instrument. The current investor narrative centers on a genuine operational turnaround — management's theatre-portfolio optimization and cost discipline have driven record EBITDA and a return to positive operating income in recent quarters — set against persistent dilution from equity offerings, a still-negative bottom line, and a leveraged balance sheet that consumes roughly $140 million per quarter in interest expense. Debate now hinges on whether improving attendance and premium-format mix can outrun shareholder dilution and refinancing risk, with recent headlines highlighting both EBITDA momentum from a leaner theatre base and investor frustration over a $200 million equity raise that diluted existing holders even as summer box office outperformed.…
AMC
AMC Theatres
$2.98
Related headlines
Investment Opinion: Should I buy AMC Today?
The synthesized recommendation is Hold, reflecting a balanced view of AMC's operational turnaround against its significant financial risks. The analyst consensus rating is 'hold' with a recommendation mean of 2.71, and the average target price of $2.88 implies only +6.8% upside from the current $2.70, suggesting the stock is fairly valued after its six-month surge. The core thesis is that AMC's EBITDA momentum and deep value on a PS basis are offset by negative free cash flow, heavy debt, and persistent dilution, warranting a neutral stance until sustainable profitability is demonstrated.
Supporting evidence includes the 21.21% year-over-year revenue growth in Q1 2026, the swing to positive EBITDA of $100.7 million, and the strong gross margin of 69.2%. However, the trailing net margin is -13.04%, free cash flow is -$123.6 million, and the current ratio of 0.41 highlights liquidity concerns. The PS ratio of 0.165x is well below the 1.0x-1.5x range for media peers, but the EV/EBITDA of 39.44x shows the enterprise is expensive once debt is considered. Analyst targets range from $1.80 to $4.00, a wide spread indicating high uncertainty.
The biggest risks that could invalidate the thesis are a deterioration in box office attendance, a failed refinancing, or accelerated dilution. The rating would upgrade to Buy if free cash flow turns positive and debt reduction accelerates, or downgrade to Sell if revenue growth decelerates below 10% or liquidity worsens. Relative to its history, the PS ratio is at the bottom of its band, suggesting the stock is undervalued on a sales basis, but the negative earnings and high leverage justify a cautious view. Overall, AMC appears fairly valued with a slight undervaluation on sales, but the risk profile prevents a stronger recommendation.
Sign up to view all
AMC 12-Month Price Forecast
AMC presents a mixed picture: operational improvements are real, with EBITDA swinging to +$100.7 million and revenue up 21.21% YoY, but the company remains unprofitable with negative free cash flow and a leveraged balance sheet. The stock's 175.31% six-month rally has stalled, and analyst sentiment is cautious, with a 'hold' rating and a target range of $1.80 to $4.00. The valuation is deeply discounted on a PS basis but expensive on an EV/EBITDA basis, reflecting the debt burden. I would upgrade to bullish if free cash flow turns positive and dilution slows, or downgrade to bearish if liquidity deteriorates or box office weakens significantly. The risk/reward is balanced, favoring a neutral stance until clearer signs of sustainable profitability emerge.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on AMC Theatres's 12-month outlook, with a consensus price target around $3.20 and implied upside of +7.4% versus the current price.
Average Target
$3.20
0 analysts
Implied Upside
+7.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$2 - $5
Analyst target range
Six analysts cover AMC, and the consensus recommendation is "hold" with a recommendation mean of 2.71 (where higher scores indicate less bullishness), reflecting a distinctly cautious Street. The average target price is $2.88, which implies roughly +6.8% upside from the current $2.70, a modest expected return that signals analysts see the stock as fairly valued after its six-month surge. The sentiment skews neutral-to-bearish rather than bullish: Citigroup has maintained a Sell rating through multiple updates (most recently May 2026), Macquarie has stayed Neutral, Roth Capital is Neutral, and only Benchmark upgraded to Buy (from Hold) in May 2026 — a distribution with no strong bullish consensus. The full target range spans $1.80 to $4.00, a wide spread of roughly 122% between low and high that signals high uncertainty and low conviction among covering analysts. The $4.00 high target implies meaningful multiple expansion and successful execution on the EBITDA turnaround — sustained box-office strength, further debt reduction, and a path to positive free cash flow — while the $1.80 low target prices in continued dilution, margin pressure, and the risk that interest expense and refinancing needs overwhelm operating improvements. The recent rating pattern shows more stagnation than momentum: the only upgrade in the past year was Benchmark's move to Buy in May 2026, while Citigroup has reiterated Sell repeatedly and Macquarie has held Neutral, indicating that analysts are waiting for clearer evidence of sustainable profitability before changing their views. The estimated average EPS of $0.035 for the forward period, with a range of -$0.09 to +$0.12, confirms that even the analyst community is split on whether AMC will be profitable at all — a razor-thin consensus that leaves the stock highly sensitive to any earnings surprise in either direction.
Drowning in data?
Find the real signal!
Bulls vs Bears: AMC Investment Factors
The bear case currently has stronger evidence due to AMC's negative free cash flow, heavy debt burden, and persistent dilution, which collectively threaten shareholder value despite operational improvements. The bull case rests on genuine EBITDA momentum and a deeply depressed PS ratio of 0.165x, but these are not yet sufficient to offset the structural financial risks. The single most important tension is whether improving attendance and premium-format mix can generate sustainable positive free cash flow before the next refinancing window, as this would determine if the equity is a value opportunity or a value trap. Analysts are cautious, with a consensus 'hold' rating and an average target of $2.88, reflecting low conviction. The stock's 2.208 beta and 69.9% max drawdown mean any resolution of this tension will likely produce outsized price moves.
Bullish
- Revenue Rebound Accelerating: Q1 2026 revenue of $1.045 billion grew 21.21% year-over-year, a sharp acceleration from the prior year's $862.5 million. This rebound, driven by a stronger release slate and premium-format mix, suggests the core exhibition business is recovering faster than the market expected.
- Record EBITDA Momentum: Q1 2026 EBITDA swung to +$100.7 million from -$5.3 million in Q1 2025, a $106 million improvement. Management's theatre-portfolio optimization and cost discipline are translating into materially higher operating leverage on each incremental dollar of revenue.
- Deep Value on Price-to-Sales: The PS ratio of 0.165x is dramatically below the 1.0x-1.5x range typical of media and entertainment peers, and well under AMC's own historical PS of 1.44x in Q4 2023. This extreme compression reflects pessimism that may already be priced in, offering asymmetric upside if profitability improves.
- Analyst Target Implies Upside: The average analyst target of $2.88 implies roughly +6.8% upside from the current $2.70, with the high target of $4.00 suggesting +48% if the EBITDA turnaround accelerates. Benchmark's upgrade to Buy in May 2026 signals early recognition of the operational improvement.
Bearish
- Persistent Negative Free Cash Flow: Trailing free cash flow is -$123.6 million, with Q1 2026 FCF of -$174.7 million and operating cash flow of -$128.5 million. The company continues to burn cash despite EBITDA improvement, relying on external financing to fund operations.
- Crushing Debt and Interest Burden: Debt-to-equity is deeply negative at -4.29, reflecting negative shareholders' equity, and interest expense consumes roughly $140 million per quarter. The current ratio of 0.41 signals weak short-term liquidity, and the EV/EBITDA of 39.44x shows the enterprise is expensive once debt is included.
- Severe Shareholder Dilution: Shares outstanding rose from 430.97 million in Q1 2025 to 539.66 million in Q1 2026, a 25% increase in just one year. The recent $200 million equity offering, highlighted in July 2026 news, continues to dilute existing holders even as box office outperforms.
- Negative Earnings and Thin Margins: Q1 2026 net loss was $117.1 million with diluted EPS of -$0.22, and the trailing net margin is -13.04%. Operating margin is just 0.84% on a trailing basis, leaving almost no cushion after $768 million of quarterly operating expenses.
AMC Technical Analysis
AMC is in a powerful recovery uptrend that has stalled into consolidation: the stock is up 175.31% over six months and 67.70% year-to-date, yet the 1-year change is -4.93%, meaning the rally is a rebound from a deep drawdown rather than a sustained multi-year advance. At $2.70, the shares sit at roughly 79% of the 52-week range (low $0.93, high $3.18), positioning them in the upper quartile of the band — close enough to highs to reflect real momentum, but far enough below $3.18 to suggest the stock has not yet confirmed a breakout. The 69.9% max drawdown underscores how violently this name can retrace, so the current positioning should be read as momentum with meaningful overextension risk rather than a safe trend. Recent momentum is modestly positive but decelerating: the 1-month change of +7.14% and 3-month change of -4.59% show short-term strength diverging from a slightly negative quarterly trend, while the 6-month gain of 175.31% dwarfs both, indicating the explosive phase has passed and the stock is digesting gains. Relative strength tells the same story — +8.10% versus SPY over one month and +157.87% over six months, but -6.59% over three months and -19.94% over one year — a classic pattern of a sharp spike followed by cooling. With a beta of 2.208, AMC is more than twice as volatile as the market, so these swings are structural, and the 67.4 million share daily volume confirms intense speculative participation that can amplify both breakouts and breakdowns. Key levels are well defined: support rests at the 52-week low of $0.93, with the $2.36-$2.46 zone (early-September lows) acting as nearer-term support, while resistance sits at the 52-week high of $3.18 and the psychologically important $3.00 handle. A decisive break above $3.18 would signal a new leg higher and validate the turnaround thesis, whereas a breakdown below $2.36 would threaten the six-month uptrend and open the door to a retest of the $1.80-$2.00 area; given the 2.208 beta, position sizing should assume daily moves roughly twice the market's, making stop discipline essential.
Beta
2.17
2.17x market volatility
Max Drawdown
-69.9%
Largest decline past year
52-Week Range
$1-$3
Price range past year
Annual Return
+8.8%
Cumulative gain past year
| Period | AMC Return | S&P 500 |
|---|---|---|
| 1m | +10.4% | +0.6% |
| 3m | +35.5% | +2.4% |
| 6m | +74.3% | +7.8% |
| 1y | +8.8% | +15.4% |
| ytd | +85.1% | +12.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AMC Fundamental Analysis
AMC's revenue trajectory is improving but uneven: Q1 2026 revenue of $1.045 billion grew 21.21% year-over-year against Q1 2025's $862.5 million, a strong rebound, yet it remains below the $1.288 billion posted in Q4 2025 and the $1.300 billion in Q3 2025, reflecting the seasonal and content-dependent nature of exhibition. The multi-quarter arc shows Q1 2025 at $862.5 million, Q2 2025 at $1.398 billion, Q3 2025 at $1.300 billion, Q4 2025 at $1.288 billion, and Q1 2026 at $1.045 billion — a pattern where year-over-year growth is positive but sequential comparisons are dictated by the film-release calendar. Segment data for the most recent period shows admissions of $578.4 million, food and beverage of $347.3 million, advertising of $37.3 million, and other product/service revenue of $119.7 million, confirming that roughly 55% of revenue comes from ticket sales and that the higher-margin concessions business is the critical profit lever. The investment case therefore depends on whether premium formats and food-and-beverage attach rates can lift revenue per patron enough to offset flat-to-modest attendance growth. Profitability remains the central problem: Q1 2026 produced a net loss of $117.1 million and diluted EPS of -$0.22, though this was a marked improvement from the -$0.47 EPS and -$202.1 million net loss in Q1 2025. Gross margin is genuinely strong at 69.2% in Q1 2026 (versus 69.6% a year earlier), and the trailing gross margin of 66.96% is healthy for the industry, but operating income was still -$44.6 million in Q1 2026 and the operating margin of just 0.84% on a trailing basis shows how thin the cushion is after $768 million of quarterly operating expenses and $139.9 million of interest expense. The net margin of -13.04% and negative EPS of -$0.79 reflect a business that is operationally close to breakeven but structurally unprofitable after its debt service, and the Q3 2025 EBITDA of -$78.3 million versus Q1 2026's +$100.7 million illustrates how violently quarterly results swing with the release slate. The balance sheet is the key risk: debt-to-equity is deeply negative at -4.29 (reflecting negative shareholders' equity), the current ratio of 0.41 signals weak short-term liquidity, and free cash flow is -$123.6 million on a trailing basis, with Q1 2026 free cash flow of -$174.7 million and operating cash flow of -$128.5 million. Cash on hand fell to $380.9 million at Q1 2026 from $477.3 million at year-end 2025, and the company relied on $63.4 million of common stock issuance plus $49.3 million of net financing in the quarter — clear evidence that AMC depends on external capital rather than internal cash generation to fund operations. The reported ROE of 33.38% is a statistical artifact of negative equity and should not be read as a sign of profitability; the more meaningful signal is the negative FCF and the reliance on equity issuance, which keeps dilution risk front and center for shareholders.
Quarterly Revenue
$1.6B
2026-06
Revenue YoY Growth
+14.2%
YoY Comparison
Gross Margin
65.7%
Latest Quarter
Free Cash Flow
$-21400000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AMC Overvalued?
Because AMC's net income is negative (trailing EPS of -$0.79, Q1 2026 net loss of $117.1 million), the PE ratio is not meaningful — the trailing PE of -1.27 and forward PE of -33.75 are both negative and uninformative — so the appropriate primary metric is the price-to-sales ratio, which stands at 0.165x on a trailing basis. That extremely low PS multiple reflects a market capitalization of roughly $800 million against estimated revenue of about $6.08 billion, and the gap between the negative trailing PE and the negative forward PE offers no growth signal; instead, the more telling figure is the forward EPS estimate of +$0.035, which implies the market expects a swing to marginal profitability. The EV/Sales of 1.789x and EV/EBITDA of 39.44x show that once debt is included, AMC is far more expensive than the equity-only PS ratio suggests — the enterprise value is burdened by a heavy debt load, and the 39.4x EV/EBITDA multiple is rich for a low-growth exhibitor. Peer comparison is difficult because AMC's negative earnings and negative book value (PB of -0.42) make standard multiples unusable, but its PS of 0.165x is dramatically below the roughly 1.0x-1.5x range typical of media and entertainment peers, a discount that reflects its leverage, dilution history, and negative margins rather than a hidden bargain. The premium embedded in the 39.44x EV/EBITDA versus the depressed 0.165x PS is the clearest signal that the equity is a thin residual claim on a heavily indebted enterprise. Historically, AMC's PS ratio has compressed dramatically: it stood at 1.44x in Q4 2023, 1.26x in Q4 2024, 0.62x in Q4 2025, and 0.51x in Q1 2026, versus the current 0.165x — meaning the stock is trading near the very bottom of its own historical valuation band. That compression reflects both the collapse in share price from prior highs and the massive increase in share count from repeated equity issuance, and it suggests the market is pricing in severe skepticism about the company's ability to generate durable profits; whether this is a value opportunity or a value trap hinges entirely on whether EBITDA momentum can translate into positive free cash flow before the next refinancing window.
PE
-1.3x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
39.4x
Enterprise Value Multiple
Investment Risk Disclosure
AMC faces severe financial and operational risks rooted in its leveraged balance sheet and cash burn. Debt-to-equity is -4.29, reflecting negative shareholders' equity, and interest expense runs about $140 million per quarter, consuming a massive portion of EBITDA. Free cash flow is -$123.6 million on a trailing basis, with Q1 2026 FCF of -$174.7 million, and the current ratio of 0.41 indicates weak liquidity. The company relies on equity issuance, as seen with $63.4 million of common stock issuance in Q1 2026, which dilutes shareholders and highlights dependence on external capital. Revenue concentration in admissions (55% of Q1 2026 revenue) and the seasonal, content-dependent nature of box office add volatility, with quarterly EBITDA swinging from -$78.3 million in Q3 2025 to +$100.7 million in Q1 2026.
Market and competitive risks are amplified by AMC's premium valuation on an enterprise basis and its high beta. The EV/EBITDA of 39.44x is rich for a low-growth exhibitor, and the PS ratio of 0.165x, while low, reflects deep skepticism that may persist. Beta of 2.208 means the stock is more than twice as volatile as the market, exposing it to sector rotation and macro sensitivity; a risk-off environment could trigger sharp declines. Competitive threats from streaming and alternative entertainment continue to pressure theatrical attendance, and regulatory headwinds are minimal but the industry faces secular challenges. Recent news highlights dilution concerns, with a $200 million equity offering in July 2026 that caused the stock to slide despite strong summer box office, indicating that investor frustration over dilution can override operational successes.
The worst-case scenario involves a chain of events where a weak film slate leads to declining attendance, EBITDA turns negative, and the company is forced into another dilutive equity raise or a distressed refinancing. This could drive the stock toward its 52-week low of $0.93, representing a -65.6% loss from the current $2.70. The analyst low target of $1.80 implies a -33.3% decline, but given the 69.9% max drawdown and 2.208 beta, a retest of the low is plausible in a severe downturn. Investors could lose over 65% of their capital if the turnaround stalls and liquidity concerns escalate.
FAQ
The most severe risk is financial: AMC has negative free cash flow of -$123.6 million and a current ratio of 0.41, indicating potential liquidity issues. Debt-to-equity is -4.29, and interest expense of ~$140 million per quarter consumes a large portion of EBITDA, leaving little room for error. Competitive risks include the secular decline in theatrical attendance due to streaming, which pressures revenue growth. Company-specific risks include persistent dilution, with shares outstanding increasing 25% year-over-year to 539.66 million, and the recent $200 million equity offering that frustrated investors. Macro risks are amplified by a beta of 2.208, making the stock highly sensitive to market downturns and sector rotation. Ranked by severity: financial, dilution, competitive, and macro.
The 12-month forecast is based on three scenarios: bull (25% probability, target $3.50-$4.00), base (50%, target $2.50-$3.00), and bear (25%, target $1.80-$2.00). The base case is most likely, assuming moderate box office performance and continued EBITDA improvement but negative free cash flow, with the stock trading around the analyst average target of $2.88. The bull case requires a strong film slate and positive free cash flow, while the bear case assumes a weak slate and liquidity concerns. Key assumptions include revenue growth of 5-10% and stable interest expense. The wide target range reflects high uncertainty, and the stock's high beta means outcomes could be volatile.
AMC appears undervalued on a price-to-sales basis, with a PS ratio of 0.165x compared to its historical average of around 1.0x-1.5x and media peers. However, this discount reflects the company's negative earnings, high debt, and dilution history, making it a potential value trap. On an enterprise basis, the EV/EBITDA of 39.44x is expensive for a low-growth exhibitor, indicating that the equity is a thin residual claim on a heavily indebted enterprise. The market is pricing in severe skepticism about AMC's ability to generate durable profits, as evidenced by the negative PE ratios and the wide analyst target range of $1.80 to $4.00. Fair value likely lies near the analyst average of $2.88, suggesting the stock is fairly valued at current levels.
AMC is a high-risk, high-reward speculative stock that may not be suitable for all investors. The analyst consensus is 'hold' with an average target of $2.88, implying only +6.8% upside from the current $2.70, while the low target of $1.80 suggests a -33% downside. The company has shown operational improvements, with Q1 2026 revenue up 21.21% YoY and EBITDA of $100.7 million, but it remains unprofitable with negative free cash flow of -$123.6 million and a current ratio of 0.41. The biggest downside risk is another dilutive equity raise or a failed refinancing, which could drive the stock toward its 52-week low of $0.93. For risk-tolerant investors with a long time horizon, a small position could be justified if they believe in the turnaround, but it is not a good buy for conservative portfolios.
AMC is more suitable for short-term trading than long-term investment due to its high volatility (beta 2.208), negative earnings, and lack of dividends. The stock has a 69.9% max drawdown and a 1-year change of -4.93%, indicating significant risk of capital loss over extended periods. Long-term investors would need to believe in a successful turnaround and sustainable profitability, which is not yet evident. For short-term traders, the high daily volume of 67.4 million shares and defined support/resistance levels ($2.36-$3.18) offer opportunities. A suggested minimum holding period for a long-term position would be at least 2-3 years to allow for potential deleveraging and free cash flow generation, but this comes with substantial risk.
